Covered recipient · General Payments record
MARIA SOLIS MAYORGA
General Payments · PY2022–2024
$784.24
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.49 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $124.81 | 1 |
| ABBVIE INC. | $50.94 | 2 |
| LivaNova USA, Inc. | $41.17 | 2 |
| Amgen Inc. | $27.26 | 1 |
| Mallinckrodt Hospital Products Inc. | $22.33 | 1 |
| Biogen, Inc. | $22.08 | 1 |
| Octapharma USA, Inc. | $21.08 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.94 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113850289 | CMS |
| ABBVIE INC. | $20.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113850283 | CMS |
| Amgen Inc. | $27.26 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111712880 | CMS |
| Biogen, Inc. | $22.08 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831534 | CMS |
| JAZZ PHARMACEUTICALS INC. | $124.81 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150212421 | CMS |
| LivaNova USA, Inc. | $19.33 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789485 | CMS |
| LivaNova USA, Inc. | $21.84 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789495 | CMS |
| Mallinckrodt Hospital Products Inc. | $22.33 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145140315 | CMS |
| Octapharma USA, Inc. | $21.08 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142319515 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.82 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118986214 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.